Molecular Diagnostics
Biomarker Identified for Aggressive Thyroid Cancer
A biomarker has been identified for the aggressive disease of papillary thyroid cancer, which comprises about 90% of all thyroid cancers and treatment of the disease historically relied upon a combination of surgery and radioactive iodine ablation with few alternatives if the disease progresses. More...25 Nov 2016
Blood Test May Help Identify Fetal Alcohol Spectrum Disorders
Fetal alcohol syndrome is a severe form of a spectrum of mental and physical disabilities called fetal alcohol spectrum disorders (FASD) that can affect children's development with long-lasting consequences and a blood test has been developed to predict the severity of disability. More...25 Nov 2016
Molecular Signature Identified for Aggressive Brain Tumor
Meningiomas are the most common primary brain tumors, but the term encompasses over a dozen subtypes that range from benign to highly aggressive. Rhabdoid meningiomas are classified as highly aggressive due to their high rates of recurrence and mortality, but the experience and outcomes for patients with this rare form of brain tumor vary widely. More...23 Nov 2016
Software Platform Provides Capabilities for Somatic Variation Analysis
An upgraded information-processing platform enables clinical genetics and molecular pathology laboratories to achieve higher performance and efficiency in somatic variation analysis of tumor-tissue sequencing data and in reporting of tissue-typing results, among other features. More...22 Nov 2016
Gene Sets Identified May Predict Response to RA Therapies
A blood biomarkers search has identified 3 gene expression signatures that helped predict which patients were more likely to respond to tumor necrosis factor inhibitors (TNFi) or B-cell depletion therapies in patients with moderate to severe rheumatoid arthritis (RA). The findings were presented at the 2016 ACR/ARHP Annual Meeting of the American College of Rheumatology and its Association of Rheumatology Health Professionals. More...22 Nov 2016
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Gold Member
Hybrid Pipette
SWITCH
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
In Other News
Identification of Gene Defects Helps Prostate Cancer Treatment
Prenatal Genetic Test Is Accurate Five Weeks into Pregnancy
Disease Genes Effect May Be Overcome by Other Gene Mutations
Vascular Development Gene Helps Protect Against Stroke Damage
Common Gene Sets Disrupted in Major Psychiatric Disorders
Early Childhood Screening Helps Prevent Heart Attacks
New Genetic Factors Linked to HPV-Related Cancers
Testing Method Clinically Ascertains Genetic Basis for Hypercholesterolemia
Gene Abnormality Found to Underlie Rare Neurological Disease
Non-Invasive Assay Improves Surveillance of Solid-Organ Transplants
Low Cost Method Examines Single Leukemic Cells
Commercial Molecular Assay Validated for Dengue Virus Outbreak
Blood Test for Colorectal Cancer Recurrence Proves Highly Sensitive
DNA-Based Analysis Detects Group A Streptococcus
Gene Activity Mapping Points to Two Subtypes of Crohn's Disease
Liquid Biopsy Tests Identified Cell-Free Tumor DNA Mutations
Simple Blood Test Vastly Improves Severe Liver Disease Detection
Strange Chimeras Defy Scientific Understanding of Human Genetics
New Genetic Links Identified for Heart Disease Risk Factors
Field Test Allows Rapid Diagnosis of Chikungunya Virus Infection
Quantitative Molecular Diagnostic Methods Identify Causes of Childhood Diarrhea
Genomic Fingerprinting Helps Predict Prostate Tumor Aggressiveness
Extended Multilocus Sequence Typing Developed for Leptospirosis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.